INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

Go back to INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
(NASDAQ: INMB) Delayed: 1.45 --0 (-0%)
Previous Close $1.45    52 Week High
Open $1.45    52 Week Low
Day High $1.45    P/E N/A 
Day Low $1.45    EPS
Volume 2,856       

(NASDAQ: INMB) Delayed: 1.45 --0 (-0%)
Previous Close $1.45    52 Week High
Open $1.45    52 Week Low
Day High $1.45    P/E N/A 
Day Low $1.45    EPS
Volume 2,856